Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.
Also called NCT01425164
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 220 participants
- Registry
-
NCT01425164
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01425164. Randomized; triple masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
- Condition
- Coronary Heart Disease
- Condition
- Angina
- Condition
- Hemodialysis
- Intervention (Drug)
- Ivabradine
- Intervention (Drug)
- Carvedilol
- Lead sponsor
- University of Campania Luigi Vanvitelli
- Collaborator
- IRCCS San Raffaele
Record details
- Record id
cardio:ct-nct01425164- Content hash
fb7c070a2e1356e8b2a4cefdd36a14723a7e231f459ee1de56b89da2749a7528